Advertisement
Screener

GILEAD SCIENCES, INC. (GILD) Deferred Tax Assets, Equity Method Investments

1.8 / 5 stars · 42/120 Roast Me

GILEAD SCIENCES, INC. Deferred Tax Assets, Equity Method Investments

GILEAD SCIENCES, INC. (GILD) had Deferred Tax Assets, Equity Method Investments of $111.00 million as of 2025-12-31, per its 10-K filed 2026-02-24.

Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross

us-gaap:DeferredTaxAssetsEquityMethodInvestments · last filed 2026-02-24

  • 2025-12-31: Deferred Tax Assets, Equity Method Investments $111.00M.
  • 2024-12-31: Deferred Tax Assets, Equity Method Investments $237.00M.
  • 2023-12-31: Deferred Tax Assets, Equity Method Investments $221.00M.
  • 2022-12-31: Deferred Tax Assets, Equity Method Investments $196.00M.
Period endDeferred Tax Assets, Equity Method InvestmentsDeferred Tax Assets, Equity Method Investments as first filed
2025-12-31$111.00M
10-K · filed 2026-02-24
2024-12-31$237.00M
10-K · filed 2026-02-24
2023-12-31$221.00M
10-K · filed 2025-02-28
2022-12-31$196.00M
10-K · filed 2024-02-23
2021-12-31$129.00M
10-K · filed 2023-02-22
$117.00M
10-K · filed 2022-02-23
2020-12-31$116.00M
10-K · filed 2022-02-23
2019-12-31$0.00
10-K · filed 2021-02-25

Similar stocks

Stock NameCountryMarket CapPE Ratio
AMGEN INC (AMGN)United States$219.567B22.39
Moderna, Inc. (MRNA)United States$77.819B-8.86
Revolution Medicines, Inc. (RVMD)United States$42.805B-22.69
BIOGEN INC. (BIIB)United States$33.427B19.60
EXELIXIS, INC. (EXEL)United States$14.358B16.15
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
Twist Bioscience Corp (TWST)United States$11.540B-47.21
BIO-TECHNE Corp (TECH)United States$11.379B74.68
REPLIGEN CORP (RGEN)United States$10.755B185.31